Crispr Therapeutics shares owned by Monashee Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Monashee Investment Management
from 13F filings
Historical chart of Monashee Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Monashee Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.4M | 50k | 47.57 |
| 2018-09-30 | $4.9M | 110k | 44.35 |
| 2017-03-31 | $473k | 22k | 21.32 |
| 2016-12-31 | $146k | 7.2k | 20.32 |
More positions owned by Monashee Investment Management
View all positions for Monashee Investment Management